Video index

1. Call to order

2. Consideration of April 24, 2026, draft meeting minutes

3. Public comment and discussion on the drug classes to be reviewed for the Medicaid Preferred Drug List (PDL):

4. Public comment and discussion on single new drugs to be reviewed for the Medicaid PDL:

5. Therapeutic and clinical drug reviews and updates, discussion, and recommendations: Gainwell Technologies and DURB members

6. Executive work session

7. Announcements of drugs recommended for the Medicaid PDL: OptumRx

8. Prospective prior authorization proposals: Acentra Health

9.Retrospective drug utilization review (DUR): Acentra Health

10. Retrospective drug use criteria for outpatient use in Vendor Drug Program: The University of Texas at Austin College of Pharmacy

11. Review of action items for next meeting: October 23, 2026, 9:00 a.m.

Jul 24, 2026 Drug Utilization Review Board (DURB)

Full agenda
Share this video

1. Call to order

2. Consideration of April 24, 2026, draft meeting minutes

3. Public comment and discussion on the drug classes to be reviewed for the Medicaid Preferred Drug List (PDL):

4. Public comment and discussion on single new drugs to be reviewed for the Medicaid PDL:

5. Therapeutic and clinical drug reviews and updates, discussion, and recommendations: Gainwell Technologies and DURB members

6. Executive work session

7. Announcements of drugs recommended for the Medicaid PDL: OptumRx

8. Prospective prior authorization proposals: Acentra Health

9.Retrospective drug utilization review (DUR): Acentra Health

10. Retrospective drug use criteria for outpatient use in Vendor Drug Program: The University of Texas at Austin College of Pharmacy

11. Review of action items for next meeting: October 23, 2026, 9:00 a.m.

© 2003-2026 Swagit Productions, LLC